EECP for Coronary Artery Disease (CAD) Package Details

• 大動脈内バルーンパンピング
• Electrocardiogram (ECG)
• Consultation with a doctor
• Coffee Zone

• Transfer airport-hotel-clinic-airport

EECP is an FDA-approved, non-invasive therapy proven to increase blood flow to the heart and other parts of the body. It works by utilizing the rhythmic inflation and deflation of pressure cuffs around the legs and buttocks, synchronized with the patient's heartbeat.
🎯 Key Benefits for Coronary Artery Disease (CAD) Patients
1. Enhanced Blood CirculationNatural Bypass Effect (Collateral Circulation): EECP stimulates the growth of new, tiny blood vessels (collateral circulation) around blocked coronary arteries. These vessels act as a "natural bypass," ensuring the heart muscle receives more oxygen-rich blood.Reduced Cardiac Workload: The therapy helps decrease the resistance the heart must pump against (Afterload), allowing the heart to function more efficiently and reducing strain.

2. Angina Relief and Symptom ReductionReduced Frequency and Severity: Patients suffering from chronic stable angina often experience a significant reduction in the frequency and intensity of chest pain, leading to an improved quality of life.Decreased Medication Dependency: Following the treatment course, many patients are able to reduce their reliance on chest pain relief medications, such as nitroglycerin.
3. Improved Quality of LifeIncreased Exercise Tolerance: Better blood supply to the heart results in improved stamina and endurance. Patients can engage in daily activities and exercise for longer periods without experiencing fatigue or chest pain.Safe and Comfortable:
EECP is a relaxing treatment experience where patients lie comfortably on a padded table and can enjoy activities like reading or watching TV during the 60-minute sessions.

📝 EECP Package Program Structure
DetailRecommended ValueStandard Sessions35 sessions (Standard EECP Protocol)
Frequency5–7 sessions per weekDuration per
Session60 minutes per sessionTotal Program
DurationApproximately 7–8 weeks

Monitoring and Follow-upSymptom assessment and Exercise Tolerance Testing (ETT) performed both before and after the full course of treatment.

• 専任医療コーディネーター
• 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
• 医療旅行中の患者擁護